CRRTF News and Press, Coronet Carpets Inc From 10/28/19

Sundial and Crescita Sign Exclusive Partnership to Develop Cannabis and Hemp Topicals Canada NewsWire CALGARY and LAVAL, QC, Oct. 28, 2019 CALGARY and LAVAL, QC , Oct. 28,  2019 /CNW/ - Sundial Growers Inc. (Nasdaq: SNDL) ("Sundial"), a Canadian licensed produce...

Crescita Therapeutics Inc. to Present at the Fall Investor Summit on September 16th-17th in New York City Canada NewsWire LAVAL, QC, Sept. 5, 2019 LAVAL, QC , Sept. 5, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the Company), a...

Crescita Therapeutics ( OTC:CRRTF ): Q2 GAAP EPS of C$0.10. More news on: Crescita Therapeutics Inc., Earnings news and commentary, , Read more ...

Crescita Reports Profitable 2019 Second Quarter Results Canada NewsWire LAVAL, QC, Aug. 8, 2019 Record Revenue of $9.4 Million and Adjusted EBITDA of $5.1 Million LAVAL, QC , Aug. 8, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita...

Noteworthy events during the week of July 21 - 27 for healthcare investors. More news on: Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Healthcare stocks news, , Read more ...

LAVAL, QC , July 16, 2019 /PRNewswire/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin...

Crescita Therapeutics to Host Investor Webcast on July 24, 2019 Canada NewsWire LAVAL, QC, July 11, 2019 LAVAL, QC , July 11, 2019 /CNW/ - Crescita Therapeutics Inc. ("Crescita" or the "Company") (TSX: CTX) (OTC US: CRRTF), a commercial dermatology company with a portfoli...

Crescita Therapeutics Inc. Receives 2nd Instalment of Up-Front Payment of €1.25 Million Following First Commercial Sale of Pliaglis by Cantabria in Italy Canada NewsWire LAVAL, QC, July 4, 2019 LAVAL, QC , July 4, 2019 /CNW/ - Crescita Therapeutics Inc. ("Cres...

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid Canada NewsWire LAVAL, QC, June 26, 2019 LAVAL, QC , June 26, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (" Crescita " or the " Company ") announced today that the Toronto Stock E...

Crescita Therapeutics Inc. Announces Intention to Make Normal Course Issuer Bid Canada NewsWire LAVAL, QC, June 17, 2019 LAVAL, QC , June 17, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (" Crescita " or the " Company "), a Canadian commercial dermat...